Fluid retention and Basal cell carcinoma

Summary:

Basal cell carcinoma is found among people with Fluid retention, especially for people who are male, 60+ old.

The study analyzes which people have Basal cell carcinoma with Fluid retention. It is created by eHealthMe based on reports of 93 people who have Fluid retention from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Fluid retention?

Fluid retention (an abnormal accumulation of fluid in the blood) is found to be associated with 1,700 drugs and 2,448 conditions by eHealthMe. Check the latest studies of Fluid retention.

What is Basal cell carcinoma?

Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills) is found to be associated with 1,093 drugs and 1,381 conditions by eHealthMe. Check the latest studies of Basal cell carcinoma.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 24, 2026

93 people who have Fluid Retention and Basal Cell Carcinoma are studied.

Would you have Basal cell carcinoma when you have Fluid retention?

Gender of people who have Fluid Retention and experienced Basal Cell Carcinoma *:

female: 15.56 %
male: 84.44 %

Age of people who have Fluid Retention and experienced Basal Cell Carcinoma *:

Common co-existing conditions for these people *:

High Blood Cholesterol: 73 people, 78.49%
Cardiac Disorder: 45 people, 48.39%
High Blood Pressure: 44 people, 47.31%
Abdominal Discomfort: 42 people, 45.16%
Prostate Infection: 42 people, 45.16%
Blood Pressure Abnormal: 39 people, 41.94%
Multiple Myeloma (cancer of the plasma cells): 22 people, 23.66%
Pain: 19 people, 20.43%
Seasonal Allergy (allergic condition due to certain season): 16 people, 17.20%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 15 people, 16.13%

Common drugs taken by these people *:

Furosemide: 46 people, 49.46%
Carvedilol: 43 people, 46.24%
Sodium Bicarbonate: 43 people, 46.24%
Hygroton: 43 people, 46.24%
Candesartan Cilexetil: 43 people, 46.24%
Tacrolimus: 43 people, 46.24%
Torsemide: 43 people, 46.24%
Prograf: 42 people, 45.16%
Aranesp: 42 people, 45.16%
Tamsulosin Hydrochloride: 41 people, 44.09%

Common symptoms for these people *:

Squamous Cell Carcinoma Of Skin (a cancer of a kind of epithelial cell, the squamous cell. these cells are the main part of the epidermis of the skin): 67 people, 72.04%
Actinic Keratosis (skin disease due to sun exposure): 58 people, 62.37%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 58 people, 62.37%
Dizziness: 57 people, 61.29%
Haemoglobin Decreased: 57 people, 61.29%
Bradycardia (abnormally slow heart action): 57 people, 61.29%
Haemorrhoids (a swollen vein or group of veins in the region of the anus): 57 people, 61.29%
Muscle Aches (muscle pain): 56 people, 60.22%
Enlarged Prostate: 55 people, 59.14%
Spinal Osteoarthritis (joint cartilage loss in spine): 55 people, 59.14%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Basal cell carcinoma?

- Check whether Basal cell carcinoma is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Fluid retention (79,660 reports)
Basal cell carcinoma (26,984 reports)

All the drugs that are associated with Basal cell carcinoma:

Basal cell carcinoma (1,093 drugs)

All the conditions that are associated with Basal cell carcinoma:

Basal cell carcinoma (1,381 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Basal cell carcinoma and Fluid retention, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.